nodes	percent_of_prediction	percent_of_DWPC	metapath
Prazosin—ABCG2—Carboplatin—brain cancer	0.0526	0.467	CbGbCtD
Prazosin—HTR1D—meninx—brain cancer	0.0468	0.0982	CbGeAlD
Prazosin—ABCG2—Etoposide—brain cancer	0.0442	0.392	CbGbCtD
Prazosin—HTR1D—dura mater—brain cancer	0.0431	0.0904	CbGeAlD
Prazosin—MT3—telencephalic ventricle—brain cancer	0.0364	0.0763	CbGeAlD
Prazosin—MT3—ganglion—brain cancer	0.0226	0.0475	CbGeAlD
Prazosin—HTR1D—trigeminal nerve—brain cancer	0.0185	0.0389	CbGeAlD
Prazosin—MT3—hindbrain—brain cancer	0.0172	0.036	CbGeAlD
Prazosin—KCNH6—ganglion—brain cancer	0.0161	0.0338	CbGeAlD
Prazosin—ABCB1—Etoposide—brain cancer	0.0159	0.141	CbGbCtD
Prazosin—HTR1D—cranial nerve—brain cancer	0.0132	0.0277	CbGeAlD
Prazosin—HTR1D—telencephalic ventricle—brain cancer	0.0107	0.0225	CbGeAlD
Prazosin—MT3—brainstem—brain cancer	0.00984	0.0206	CbGeAlD
Prazosin—HTR1A—telencephalic ventricle—brain cancer	0.00895	0.0188	CbGeAlD
Prazosin—MT3—telencephalon—brain cancer	0.00873	0.0183	CbGeAlD
Prazosin—MT3—medulla oblongata—brain cancer	0.00686	0.0144	CbGeAlD
Prazosin—SLC22A1—ganglion—brain cancer	0.00674	0.0141	CbGeAlD
Prazosin—HTR1D—ganglion—brain cancer	0.00668	0.014	CbGeAlD
Prazosin—KCNH6—telencephalon—brain cancer	0.00622	0.0131	CbGeAlD
Prazosin—MT3—spinal cord—brain cancer	0.00612	0.0128	CbGeAlD
Prazosin—Gynaecomastia—Procarbazine—brain cancer	0.00604	0.0202	CcSEcCtD
Prazosin—HTR1A—ganglion—brain cancer	0.00557	0.0117	CbGeAlD
Prazosin—MT3—endocrine gland—brain cancer	0.00551	0.0116	CbGeAlD
Prazosin—MT3—head—brain cancer	0.00544	0.0114	CbGeAlD
Prazosin—KCNH7—head—brain cancer	0.00544	0.0114	CbGeAlD
Prazosin—HTR1D—blood vessel—brain cancer	0.00531	0.0111	CbGeAlD
Prazosin—MT3—central nervous system—brain cancer	0.00496	0.0104	CbGeAlD
Prazosin—KCNH7—central nervous system—brain cancer	0.00496	0.0104	CbGeAlD
Prazosin—MT3—cerebellum—brain cancer	0.00485	0.0102	CbGeAlD
Prazosin—KCNH7—cerebellum—brain cancer	0.00485	0.0102	CbGeAlD
Prazosin—Alopecia—Lomustine—brain cancer	0.00472	0.0158	CcSEcCtD
Prazosin—HTR1A—hindbrain—brain cancer	0.00422	0.00886	CbGeAlD
Prazosin—Pancreatitis—Procarbazine—brain cancer	0.00415	0.0139	CcSEcCtD
Prazosin—Angina pectoris—Procarbazine—brain cancer	0.00413	0.0138	CcSEcCtD
Prazosin—Sweating increased—Procarbazine—brain cancer	0.00413	0.0138	CcSEcCtD
Prazosin—Urinary incontinence—Carmustine—brain cancer	0.00408	0.0136	CcSEcCtD
Prazosin—MT3—brain—brain cancer	0.00394	0.00827	CbGeAlD
Prazosin—KCNH7—brain—brain cancer	0.00394	0.00827	CbGeAlD
Prazosin—Urinary incontinence—Temozolomide—brain cancer	0.00394	0.0132	CcSEcCtD
Prazosin—Pollakiuria—Procarbazine—brain cancer	0.00391	0.0131	CcSEcCtD
Prazosin—ADRA1A—hindbrain—brain cancer	0.00389	0.00817	CbGeAlD
Prazosin—KCNH6—head—brain cancer	0.00388	0.00813	CbGeAlD
Prazosin—Gynaecomastia—Carmustine—brain cancer	0.00378	0.0126	CcSEcCtD
Prazosin—Drowsiness—Procarbazine—brain cancer	0.00378	0.0126	CcSEcCtD
Prazosin—Pain—Carboplatin—brain cancer	0.00371	0.0124	CcSEcCtD
Prazosin—Epistaxis—Procarbazine—brain cancer	0.00356	0.0119	CcSEcCtD
Prazosin—KCNH6—central nervous system—brain cancer	0.00354	0.00742	CbGeAlD
Prazosin—ADRA1D—telencephalon—brain cancer	0.00345	0.00723	CbGeAlD
Prazosin—Body temperature increased—Carboplatin—brain cancer	0.00343	0.0115	CcSEcCtD
Prazosin—Eye pain—Carmustine—brain cancer	0.0034	0.0114	CcSEcCtD
Prazosin—Hallucination—Procarbazine—brain cancer	0.00337	0.0113	CcSEcCtD
Prazosin—Eye pain—Temozolomide—brain cancer	0.00328	0.011	CcSEcCtD
Prazosin—Nasal congestion—Temozolomide—brain cancer	0.00325	0.0109	CcSEcCtD
Prazosin—Pancreatitis—Hydroxyurea—brain cancer	0.00321	0.0107	CcSEcCtD
Prazosin—Flushing—Procarbazine—brain cancer	0.00315	0.0105	CcSEcCtD
Prazosin—Body temperature increased—Lomustine—brain cancer	0.003	0.01	CcSEcCtD
Prazosin—Alopecia—Procarbazine—brain cancer	0.003	0.01	CcSEcCtD
Prazosin—Drowsiness—Hydroxyurea—brain cancer	0.00292	0.00977	CcSEcCtD
Prazosin—HTR1D—brainstem—brain cancer	0.0029	0.00609	CbGeAlD
Prazosin—Tension—Procarbazine—brain cancer	0.0029	0.00968	CcSEcCtD
Prazosin—Nervousness—Procarbazine—brain cancer	0.00287	0.00958	CcSEcCtD
Prazosin—KCNH6—brain—brain cancer	0.00281	0.00589	CbGeAlD
Prazosin—Syncope—Procarbazine—brain cancer	0.00265	0.00885	CcSEcCtD
Prazosin—Hallucination—Hydroxyurea—brain cancer	0.00261	0.00873	CcSEcCtD
Prazosin—SLC22A1—telencephalon—brain cancer	0.0026	0.00546	CbGeAlD
Prazosin—Loss of consciousness—Procarbazine—brain cancer	0.00259	0.00867	CcSEcCtD
Prazosin—HTR1D—telencephalon—brain cancer	0.00258	0.00541	CbGeAlD
Prazosin—Arthralgia—Procarbazine—brain cancer	0.00251	0.0084	CcSEcCtD
Prazosin—Sweating increased—Temozolomide—brain cancer	0.00249	0.00834	CcSEcCtD
Prazosin—Dry mouth—Procarbazine—brain cancer	0.00246	0.00822	CcSEcCtD
Prazosin—HTR1A—brainstem—brain cancer	0.00242	0.00508	CbGeAlD
Prazosin—Vomiting—Lomustine—brain cancer	0.00241	0.00806	CcSEcCtD
Prazosin—Oedema—Procarbazine—brain cancer	0.00241	0.00805	CcSEcCtD
Prazosin—Shock—Procarbazine—brain cancer	0.00237	0.00792	CcSEcCtD
Prazosin—Pollakiuria—Temozolomide—brain cancer	0.00237	0.00791	CcSEcCtD
Prazosin—Erectile dysfunction—Temozolomide—brain cancer	0.00236	0.00789	CcSEcCtD
Prazosin—Tachycardia—Procarbazine—brain cancer	0.00235	0.00786	CcSEcCtD
Prazosin—Hyperhidrosis—Procarbazine—brain cancer	0.00233	0.00778	CcSEcCtD
Prazosin—Alopecia—Hydroxyurea—brain cancer	0.00232	0.00775	CcSEcCtD
Prazosin—Nausea—Lomustine—brain cancer	0.00225	0.00753	CcSEcCtD
Prazosin—ADRA1A—brainstem—brain cancer	0.00223	0.00468	CbGeAlD
Prazosin—ADRA1B—head—brain cancer	0.00219	0.0046	CbGeAlD
Prazosin—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00219	0.00734	CcSEcCtD
Prazosin—Insomnia—Procarbazine—brain cancer	0.00218	0.00728	CcSEcCtD
Prazosin—ADRA1D—endocrine gland—brain cancer	0.00217	0.00456	CbGeAlD
Prazosin—Paraesthesia—Procarbazine—brain cancer	0.00216	0.00723	CcSEcCtD
Prazosin—HTR1A—telencephalon—brain cancer	0.00215	0.00451	CbGeAlD
Prazosin—ADRA1D—head—brain cancer	0.00215	0.0045	CbGeAlD
Prazosin—Somnolence—Procarbazine—brain cancer	0.00214	0.00716	CcSEcCtD
Prazosin—Ill-defined disorder—Hydroxyurea—brain cancer	0.00212	0.00709	CcSEcCtD
Prazosin—Hallucination—Carmustine—brain cancer	0.00211	0.00706	CcSEcCtD
Prazosin—Fatigue—Procarbazine—brain cancer	0.00208	0.00694	CcSEcCtD
Prazosin—SLC22A3—gonad—brain cancer	0.00207	0.00435	CbGeAlD
Prazosin—Malaise—Hydroxyurea—brain cancer	0.00206	0.00689	CcSEcCtD
Prazosin—Constipation—Procarbazine—brain cancer	0.00206	0.00689	CcSEcCtD
Prazosin—Pain—Procarbazine—brain cancer	0.00206	0.00689	CcSEcCtD
Prazosin—Hallucination—Temozolomide—brain cancer	0.00204	0.00682	CcSEcCtD
Prazosin—ADRA1B—central nervous system—brain cancer	0.002	0.0042	CbGeAlD
Prazosin—Sweating increased—Etoposide—brain cancer	0.002	0.00667	CcSEcCtD
Prazosin—ORM1—spinal cord—brain cancer	0.00199	0.00417	CbGeAlD
Prazosin—Feeling abnormal—Procarbazine—brain cancer	0.00198	0.00664	CcSEcCtD
Prazosin—ADRA1A—telencephalon—brain cancer	0.00198	0.00415	CbGeAlD
Prazosin—Flushing—Carmustine—brain cancer	0.00197	0.00658	CcSEcCtD
Prazosin—ADRA1D—central nervous system—brain cancer	0.00196	0.00411	CbGeAlD
Prazosin—Discomfort—Hydroxyurea—brain cancer	0.00192	0.00642	CcSEcCtD
Prazosin—Urticaria—Procarbazine—brain cancer	0.00191	0.0064	CcSEcCtD
Prazosin—KCNH2—telencephalon—brain cancer	0.00191	0.00401	CbGeAlD
Prazosin—Tinnitus—Temozolomide—brain cancer	0.00191	0.00639	CcSEcCtD
Prazosin—Body temperature increased—Procarbazine—brain cancer	0.0019	0.00637	CcSEcCtD
Prazosin—Flushing—Temozolomide—brain cancer	0.0019	0.00636	CcSEcCtD
Prazosin—Alopecia—Carmustine—brain cancer	0.00187	0.00627	CcSEcCtD
Prazosin—Oedema—Hydroxyurea—brain cancer	0.00186	0.00623	CcSEcCtD
Prazosin—HTR1D—midbrain—brain cancer	0.00185	0.00388	CbGeAlD
Prazosin—Alopecia—Temozolomide—brain cancer	0.00181	0.00606	CcSEcCtD
Prazosin—ORM1—endocrine gland—brain cancer	0.00179	0.00376	CbGeAlD
Prazosin—Hypersensitivity—Procarbazine—brain cancer	0.00177	0.00593	CcSEcCtD
Prazosin—Vision blurred—Carmustine—brain cancer	0.00174	0.00582	CcSEcCtD
Prazosin—ABCB1—blood vessel—brain cancer	0.00173	0.00363	CbGeAlD
Prazosin—Asthenia—Procarbazine—brain cancer	0.00173	0.00578	CcSEcCtD
Prazosin—Pruritus—Procarbazine—brain cancer	0.0017	0.0057	CcSEcCtD
Prazosin—ABCG2—telencephalon—brain cancer	0.0017	0.00357	CbGeAlD
Prazosin—Vision blurred—Temozolomide—brain cancer	0.00168	0.00562	CcSEcCtD
Prazosin—Dyspnoea—Hydroxyurea—brain cancer	0.00166	0.00556	CcSEcCtD
Prazosin—Somnolence—Hydroxyurea—brain cancer	0.00166	0.00554	CcSEcCtD
Prazosin—Ill-defined disorder—Temozolomide—brain cancer	0.00166	0.00553	CcSEcCtD
Prazosin—Diarrhoea—Procarbazine—brain cancer	0.00165	0.00551	CcSEcCtD
Prazosin—SLC22A1—endocrine gland—brain cancer	0.00164	0.00344	CbGeAlD
Prazosin—SLC22A1—head—brain cancer	0.00162	0.0034	CbGeAlD
Prazosin—ORM1—central nervous system—brain cancer	0.00161	0.00338	CbGeAlD
Prazosin—Malaise—Temozolomide—brain cancer	0.00161	0.00538	CcSEcCtD
Prazosin—Fatigue—Hydroxyurea—brain cancer	0.00161	0.00537	CcSEcCtD
Prazosin—HTR1D—head—brain cancer	0.0016	0.00337	CbGeAlD
Prazosin—Vertigo—Temozolomide—brain cancer	0.0016	0.00536	CcSEcCtD
Prazosin—Constipation—Hydroxyurea—brain cancer	0.00159	0.00533	CcSEcCtD
Prazosin—Pain—Hydroxyurea—brain cancer	0.00159	0.00533	CcSEcCtD
Prazosin—Dizziness—Procarbazine—brain cancer	0.00159	0.00533	CcSEcCtD
Prazosin—ADRA1B—brain—brain cancer	0.00159	0.00334	CbGeAlD
Prazosin—Palpitations—Temozolomide—brain cancer	0.00158	0.00527	CcSEcCtD
Prazosin—SLC22A3—endocrine gland—brain cancer	0.00157	0.00329	CbGeAlD
Prazosin—KCNH2—pituitary gland—brain cancer	0.00156	0.00327	CbGeAlD
Prazosin—ADRA1D—brain—brain cancer	0.00156	0.00326	CbGeAlD
Prazosin—SLC22A3—head—brain cancer	0.00155	0.00325	CbGeAlD
Prazosin—HTR1A—midbrain—brain cancer	0.00154	0.00324	CbGeAlD
Prazosin—Feeling abnormal—Hydroxyurea—brain cancer	0.00154	0.00514	CcSEcCtD
Prazosin—Vomiting—Procarbazine—brain cancer	0.00153	0.00512	CcSEcCtD
Prazosin—Flushing—Etoposide—brain cancer	0.00152	0.00509	CcSEcCtD
Prazosin—Arthralgia—Temozolomide—brain cancer	0.00152	0.00508	CcSEcCtD
Prazosin—Rash—Procarbazine—brain cancer	0.00152	0.00508	CcSEcCtD
Prazosin—Dermatitis—Procarbazine—brain cancer	0.00152	0.00507	CcSEcCtD
Prazosin—Headache—Procarbazine—brain cancer	0.00151	0.00504	CcSEcCtD
Prazosin—Oedema—Carmustine—brain cancer	0.00151	0.00504	CcSEcCtD
Prazosin—ADRA2A—telencephalon—brain cancer	0.00151	0.00316	CbGeAlD
Prazosin—HTR1A—spinal cord—brain cancer	0.00151	0.00316	CbGeAlD
Prazosin—KCNH2—medulla oblongata—brain cancer	0.0015	0.00315	CbGeAlD
Prazosin—Discomfort—Temozolomide—brain cancer	0.0015	0.00502	CcSEcCtD
Prazosin—Dry mouth—Temozolomide—brain cancer	0.00149	0.00497	CcSEcCtD
Prazosin—SLC22A1—central nervous system—brain cancer	0.00148	0.0031	CbGeAlD
Prazosin—Body temperature increased—Hydroxyurea—brain cancer	0.00147	0.00493	CcSEcCtD
Prazosin—Tachycardia—Carmustine—brain cancer	0.00147	0.00492	CcSEcCtD
Prazosin—HTR1D—central nervous system—brain cancer	0.00147	0.00307	CbGeAlD
Prazosin—Oedema—Temozolomide—brain cancer	0.00146	0.00487	CcSEcCtD
Prazosin—Alopecia—Etoposide—brain cancer	0.00145	0.00485	CcSEcCtD
Prazosin—Nausea—Procarbazine—brain cancer	0.00143	0.00478	CcSEcCtD
Prazosin—SLC22A3—central nervous system—brain cancer	0.00141	0.00296	CbGeAlD
Prazosin—Hyperhidrosis—Temozolomide—brain cancer	0.00141	0.00471	CcSEcCtD
Prazosin—ABCG2—pituitary gland—brain cancer	0.00139	0.00291	CbGeAlD
Prazosin—KCNH2—midbrain—brain cancer	0.00137	0.00288	CbGeAlD
Prazosin—Hypersensitivity—Hydroxyurea—brain cancer	0.00137	0.00459	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Carmustine—brain cancer	0.00137	0.00459	CcSEcCtD
Prazosin—Insomnia—Carmustine—brain cancer	0.00136	0.00456	CcSEcCtD
Prazosin—HTR1A—endocrine gland—brain cancer	0.00136	0.00284	CbGeAlD
Prazosin—Paraesthesia—Carmustine—brain cancer	0.00135	0.00452	CcSEcCtD
Prazosin—Dyspnoea—Carmustine—brain cancer	0.00134	0.00449	CcSEcCtD
Prazosin—KCNH2—spinal cord—brain cancer	0.00134	0.00281	CbGeAlD
Prazosin—Somnolence—Carmustine—brain cancer	0.00134	0.00448	CcSEcCtD
Prazosin—HTR1A—head—brain cancer	0.00134	0.00281	CbGeAlD
Prazosin—Asthenia—Hydroxyurea—brain cancer	0.00134	0.00447	CcSEcCtD
Prazosin—ABCG2—medulla oblongata—brain cancer	0.00134	0.0028	CbGeAlD
Prazosin—Musculoskeletal discomfort—Temozolomide—brain cancer	0.00133	0.00444	CcSEcCtD
Prazosin—Ill-defined disorder—Etoposide—brain cancer	0.00132	0.00443	CcSEcCtD
Prazosin—Insomnia—Temozolomide—brain cancer	0.00132	0.0044	CcSEcCtD
Prazosin—Paraesthesia—Temozolomide—brain cancer	0.00131	0.00437	CcSEcCtD
Prazosin—Dyspnoea—Temozolomide—brain cancer	0.0013	0.00434	CcSEcCtD
Prazosin—Somnolence—Temozolomide—brain cancer	0.00129	0.00433	CcSEcCtD
Prazosin—Pain—Carmustine—brain cancer	0.00129	0.00431	CcSEcCtD
Prazosin—Constipation—Carmustine—brain cancer	0.00129	0.00431	CcSEcCtD
Prazosin—Malaise—Etoposide—brain cancer	0.00129	0.0043	CcSEcCtD
Prazosin—Vertigo—Etoposide—brain cancer	0.00128	0.00429	CcSEcCtD
Prazosin—Diarrhoea—Hydroxyurea—brain cancer	0.00128	0.00426	CcSEcCtD
Prazosin—ADRA2A—gonad—brain cancer	0.00126	0.00264	CbGeAlD
Prazosin—Fatigue—Temozolomide—brain cancer	0.00126	0.0042	CcSEcCtD
Prazosin—Loss of consciousness—Etoposide—brain cancer	0.00125	0.0042	CcSEcCtD
Prazosin—ADRA1A—endocrine gland—brain cancer	0.00125	0.00262	CbGeAlD
Prazosin—Constipation—Temozolomide—brain cancer	0.00125	0.00416	CcSEcCtD
Prazosin—Pain—Temozolomide—brain cancer	0.00125	0.00416	CcSEcCtD
Prazosin—Feeling abnormal—Carmustine—brain cancer	0.00124	0.00415	CcSEcCtD
Prazosin—ADRA1A—head—brain cancer	0.00123	0.00259	CbGeAlD
Prazosin—Dizziness—Hydroxyurea—brain cancer	0.00123	0.00412	CcSEcCtD
Prazosin—ADRA2A—pituitary gland—brain cancer	0.00123	0.00257	CbGeAlD
Prazosin—ABCG2—midbrain—brain cancer	0.00122	0.00256	CbGeAlD
Prazosin—HTR1A—central nervous system—brain cancer	0.00122	0.00256	CbGeAlD
Prazosin—KCNH2—endocrine gland—brain cancer	0.00121	0.00253	CbGeAlD
Prazosin—Discomfort—Etoposide—brain cancer	0.0012	0.00402	CcSEcCtD
Prazosin—Feeling abnormal—Temozolomide—brain cancer	0.0012	0.00401	CcSEcCtD
Prazosin—HTR1A—cerebellum—brain cancer	0.00119	0.0025	CbGeAlD
Prazosin—ABCG2—spinal cord—brain cancer	0.00119	0.0025	CbGeAlD
Prazosin—Body temperature increased—Carmustine—brain cancer	0.00119	0.00398	CcSEcCtD
Prazosin—KCNH2—head—brain cancer	0.00119	0.0025	CbGeAlD
Prazosin—Vomiting—Hydroxyurea—brain cancer	0.00119	0.00396	CcSEcCtD
Prazosin—ADRA2A—medulla oblongata—brain cancer	0.00118	0.00248	CbGeAlD
Prazosin—Rash—Hydroxyurea—brain cancer	0.00118	0.00393	CcSEcCtD
Prazosin—Dermatitis—Hydroxyurea—brain cancer	0.00117	0.00393	CcSEcCtD
Prazosin—SLC22A1—brain—brain cancer	0.00117	0.00246	CbGeAlD
Prazosin—Headache—Hydroxyurea—brain cancer	0.00117	0.0039	CcSEcCtD
Prazosin—HTR1D—brain—brain cancer	0.00116	0.00244	CbGeAlD
Prazosin—Urticaria—Temozolomide—brain cancer	0.00116	0.00387	CcSEcCtD
Prazosin—Body temperature increased—Temozolomide—brain cancer	0.00115	0.00385	CcSEcCtD
Prazosin—Tachycardia—Etoposide—brain cancer	0.00114	0.0038	CcSEcCtD
Prazosin—Hyperhidrosis—Etoposide—brain cancer	0.00113	0.00377	CcSEcCtD
Prazosin—ADRA1A—central nervous system—brain cancer	0.00113	0.00236	CbGeAlD
Prazosin—SLC22A3—brain—brain cancer	0.00112	0.00235	CbGeAlD
Prazosin—Hypersensitivity—Carmustine—brain cancer	0.00111	0.00371	CcSEcCtD
Prazosin—Nausea—Hydroxyurea—brain cancer	0.00111	0.0037	CcSEcCtD
Prazosin—ADRA1A—cerebellum—brain cancer	0.0011	0.00231	CbGeAlD
Prazosin—KCNH2—central nervous system—brain cancer	0.00109	0.00228	CbGeAlD
Prazosin—ADRA2A—midbrain—brain cancer	0.00108	0.00227	CbGeAlD
Prazosin—Asthenia—Carmustine—brain cancer	0.00108	0.00361	CcSEcCtD
Prazosin—Hypersensitivity—Temozolomide—brain cancer	0.00107	0.00359	CcSEcCtD
Prazosin—KCNH2—cerebellum—brain cancer	0.00106	0.00223	CbGeAlD
Prazosin—ADRA2A—spinal cord—brain cancer	0.00106	0.00221	CbGeAlD
Prazosin—Paraesthesia—Etoposide—brain cancer	0.00105	0.0035	CcSEcCtD
Prazosin—Asthenia—Temozolomide—brain cancer	0.00104	0.00349	CcSEcCtD
Prazosin—Dyspnoea—Etoposide—brain cancer	0.00104	0.00347	CcSEcCtD
Prazosin—Somnolence—Etoposide—brain cancer	0.00104	0.00346	CcSEcCtD
Prazosin—Diarrhoea—Carmustine—brain cancer	0.00103	0.00345	CcSEcCtD
Prazosin—Pruritus—Temozolomide—brain cancer	0.00103	0.00344	CcSEcCtD
Prazosin—CYP1A1—endocrine gland—brain cancer	0.00102	0.00214	CbGeAlD
Prazosin—CYP1A1—head—brain cancer	0.00101	0.00211	CbGeAlD
Prazosin—Fatigue—Etoposide—brain cancer	0.001	0.00336	CcSEcCtD
Prazosin—Dizziness—Carmustine—brain cancer	0.000996	0.00333	CcSEcCtD
Prazosin—Constipation—Etoposide—brain cancer	0.000996	0.00333	CcSEcCtD
Prazosin—Pain—Etoposide—brain cancer	0.000996	0.00333	CcSEcCtD
Prazosin—Diarrhoea—Temozolomide—brain cancer	0.000996	0.00333	CcSEcCtD
Prazosin—HTR1A—brain—brain cancer	0.000969	0.00203	CbGeAlD
Prazosin—Dizziness—Temozolomide—brain cancer	0.000963	0.00322	CcSEcCtD
Prazosin—Feeling abnormal—Etoposide—brain cancer	0.00096	0.00321	CcSEcCtD
Prazosin—Vomiting—Carmustine—brain cancer	0.000958	0.0032	CcSEcCtD
Prazosin—Rash—Carmustine—brain cancer	0.00095	0.00318	CcSEcCtD
Prazosin—ADRA2A—endocrine gland—brain cancer	0.00095	0.00199	CbGeAlD
Prazosin—Dermatitis—Carmustine—brain cancer	0.000949	0.00317	CcSEcCtD
Prazosin—ABCG2—cerebellum—brain cancer	0.000945	0.00198	CbGeAlD
Prazosin—Headache—Carmustine—brain cancer	0.000944	0.00316	CcSEcCtD
Prazosin—ADRA2A—head—brain cancer	0.000938	0.00197	CbGeAlD
Prazosin—Vomiting—Temozolomide—brain cancer	0.000926	0.0031	CcSEcCtD
Prazosin—Urticaria—Etoposide—brain cancer	0.000926	0.00309	CcSEcCtD
Prazosin—Body temperature increased—Etoposide—brain cancer	0.000921	0.00308	CcSEcCtD
Prazosin—CYP1A1—central nervous system—brain cancer	0.000918	0.00193	CbGeAlD
Prazosin—Rash—Temozolomide—brain cancer	0.000918	0.00307	CcSEcCtD
Prazosin—Dermatitis—Temozolomide—brain cancer	0.000917	0.00307	CcSEcCtD
Prazosin—Headache—Temozolomide—brain cancer	0.000912	0.00305	CcSEcCtD
Prazosin—Nausea—Carmustine—brain cancer	0.000895	0.00299	CcSEcCtD
Prazosin—ADRA1A—brain—brain cancer	0.000894	0.00187	CbGeAlD
Prazosin—Nausea—Temozolomide—brain cancer	0.000865	0.00289	CcSEcCtD
Prazosin—KCNH2—brain—brain cancer	0.000863	0.00181	CbGeAlD
Prazosin—Hypersensitivity—Etoposide—brain cancer	0.000858	0.00287	CcSEcCtD
Prazosin—ADRA2A—central nervous system—brain cancer	0.000856	0.00179	CbGeAlD
Prazosin—ABCB1—telencephalon—brain cancer	0.000839	0.00176	CbGeAlD
Prazosin—ADRA2A—cerebellum—brain cancer	0.000837	0.00175	CbGeAlD
Prazosin—Asthenia—Etoposide—brain cancer	0.000836	0.0028	CcSEcCtD
Prazosin—Pruritus—Etoposide—brain cancer	0.000824	0.00276	CcSEcCtD
Prazosin—Diarrhoea—Etoposide—brain cancer	0.000797	0.00267	CcSEcCtD
Prazosin—Dizziness—Etoposide—brain cancer	0.00077	0.00258	CcSEcCtD
Prazosin—ABCG2—brain—brain cancer	0.000768	0.00161	CbGeAlD
Prazosin—Vomiting—Etoposide—brain cancer	0.000741	0.00248	CcSEcCtD
Prazosin—Rash—Etoposide—brain cancer	0.000735	0.00246	CcSEcCtD
Prazosin—Dermatitis—Etoposide—brain cancer	0.000734	0.00245	CcSEcCtD
Prazosin—Headache—Etoposide—brain cancer	0.00073	0.00244	CcSEcCtD
Prazosin—CYP1A1—brain—brain cancer	0.000729	0.00153	CbGeAlD
Prazosin—ABCB1—gonad—brain cancer	0.0007	0.00147	CbGeAlD
Prazosin—Nausea—Etoposide—brain cancer	0.000692	0.00231	CcSEcCtD
Prazosin—ABCB1—pituitary gland—brain cancer	0.000683	0.00143	CbGeAlD
Prazosin—ADRA2A—brain—brain cancer	0.000679	0.00143	CbGeAlD
Prazosin—ABCB1—medulla oblongata—brain cancer	0.000659	0.00138	CbGeAlD
Prazosin—ABCB1—midbrain—brain cancer	0.000603	0.00126	CbGeAlD
Prazosin—ABCB1—spinal cord—brain cancer	0.000588	0.00123	CbGeAlD
Prazosin—ABCB1—endocrine gland—brain cancer	0.000529	0.00111	CbGeAlD
Prazosin—ABCB1—head—brain cancer	0.000522	0.0011	CbGeAlD
Prazosin—ABCB1—central nervous system—brain cancer	0.000477	0.001	CbGeAlD
Prazosin—ABCB1—cerebellum—brain cancer	0.000466	0.000978	CbGeAlD
Prazosin—ABCB1—brain—brain cancer	0.000379	0.000794	CbGeAlD
Prazosin—ADRA2A—Signaling by GPCR—SMO—brain cancer	6.03e-05	0.000541	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—PTCH1—brain cancer	6.03e-05	0.000541	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—SUFU—brain cancer	5.97e-05	0.000536	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	5.95e-05	0.000534	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—GLI2—brain cancer	5.95e-05	0.000534	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—HEY1—brain cancer	5.94e-05	0.000533	CbGpPWpGaD
Prazosin—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—brain cancer	5.9e-05	0.00053	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—VAV1—brain cancer	5.85e-05	0.000525	CbGpPWpGaD
Prazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	5.84e-05	0.000524	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—DLL1—brain cancer	5.83e-05	0.000523	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—GFAP—brain cancer	5.76e-05	0.000517	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—ENO2—brain cancer	5.75e-05	0.000516	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—HEY1—brain cancer	5.74e-05	0.000515	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—ABR—brain cancer	5.73e-05	0.000514	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—BSG—brain cancer	5.73e-05	0.000514	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—ENO2—brain cancer	5.69e-05	0.000511	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—IDH1—brain cancer	5.69e-05	0.00051	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—DLL1—brain cancer	5.62e-05	0.000505	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—GLI1—brain cancer	5.6e-05	0.000502	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—VAV1—brain cancer	5.57e-05	0.0005	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—GLI2—brain cancer	5.53e-05	0.000496	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—SHH—brain cancer	5.49e-05	0.000492	CbGpPWpGaD
Prazosin—HTR1D—GPCR downstream signaling—PIK3CG—brain cancer	5.48e-05	0.000492	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—HEY1—brain cancer	5.46e-05	0.00049	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—VAV1—brain cancer	5.45e-05	0.000489	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—CYP2C9—brain cancer	5.38e-05	0.000483	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—DLL1—brain cancer	5.36e-05	0.000481	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—SUFU—brain cancer	5.3e-05	0.000476	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—ENO2—brain cancer	5.3e-05	0.000476	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—TRPC6—brain cancer	5.29e-05	0.000475	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	5.26e-05	0.000472	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	5.21e-05	0.000467	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—SMO—brain cancer	5.2e-05	0.000467	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—PTCH1—brain cancer	5.2e-05	0.000467	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—GLI1—brain cancer	5.2e-05	0.000467	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—GFAP—brain cancer	5.12e-05	0.000459	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—PIK3CG—brain cancer	5.09e-05	0.000456	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—VAV1—brain cancer	5.06e-05	0.000454	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—PIK3CG—brain cancer	4.98e-05	0.000447	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—SHH—brain cancer	4.95e-05	0.000445	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—VAV1—brain cancer	4.95e-05	0.000444	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—SUFU—brain cancer	4.93e-05	0.000442	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—IDH1—brain cancer	4.92e-05	0.000442	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—NOTCH2—brain cancer	4.86e-05	0.000436	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—HEY1—brain cancer	4.85e-05	0.000435	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—SHH—brain cancer	4.78e-05	0.000429	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—TRPC6—brain cancer	4.78e-05	0.000429	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—DLL1—brain cancer	4.76e-05	0.000427	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—GFAP—brain cancer	4.76e-05	0.000427	CbGpPWpGaD
Prazosin—ADRA2B—Hemostasis—IL2—brain cancer	4.72e-05	0.000423	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—SMO—brain cancer	4.7e-05	0.000421	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—PTCH1—brain cancer	4.7e-05	0.000421	CbGpPWpGaD
Prazosin—ADRA1D—GPCR downstream signaling—PIK3CG—brain cancer	4.69e-05	0.000421	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—VAV1—brain cancer	4.63e-05	0.000416	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—TRPC6—brain cancer	4.61e-05	0.000414	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—VAV1—brain cancer	4.6e-05	0.000413	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	4.59e-05	0.000412	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—BSG—brain cancer	4.57e-05	0.00041	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—SHH—brain cancer	4.55e-05	0.000409	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—SMO—brain cancer	4.53e-05	0.000407	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—PTCH1—brain cancer	4.53e-05	0.000407	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—HEY1—brain cancer	4.51e-05	0.000405	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—ENO2—brain cancer	4.5e-05	0.000403	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—DLL1—brain cancer	4.42e-05	0.000397	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—TRPC6—brain cancer	4.39e-05	0.000394	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—SMO—brain cancer	4.32e-05	0.000387	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—PTCH1—brain cancer	4.32e-05	0.000387	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—PIK3CG—brain cancer	4.26e-05	0.000382	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—PIK3CG—brain cancer	4.24e-05	0.00038	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	4.22e-05	0.000379	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—PIK3CG—brain cancer	4.16e-05	0.000373	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—NOTCH2—brain cancer	4.16e-05	0.000373	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	4.13e-05	0.00037	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—PIK3CG—brain cancer	4.09e-05	0.000367	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—SHH—brain cancer	4.05e-05	0.000363	CbGpPWpGaD
Prazosin—ADRA2B—Hemostasis—VEGFA—brain cancer	4.01e-05	0.00036	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	4.01e-05	0.00036	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—HES1—brain cancer	3.98e-05	0.000358	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—VAV1—brain cancer	3.96e-05	0.000356	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—IDH1—brain cancer	3.93e-05	0.000353	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—TRPC6—brain cancer	3.9e-05	0.00035	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—PIK3CG—brain cancer	3.89e-05	0.00035	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—ENO2—brain cancer	3.89e-05	0.000349	CbGpPWpGaD
Prazosin—HTR1D—GPCR downstream signaling—IL2—brain cancer	3.86e-05	0.000346	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—PIK3CG—brain cancer	3.85e-05	0.000345	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—SMO—brain cancer	3.84e-05	0.000344	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—PTCH1—brain cancer	3.84e-05	0.000344	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—PDGFRA—brain cancer	3.79e-05	0.00034	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—SHH—brain cancer	3.76e-05	0.000337	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—NOTCH2—brain cancer	3.75e-05	0.000337	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—PIK3CG—brain cancer	3.71e-05	0.000333	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—SPP1—brain cancer	3.68e-05	0.00033	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—TRPC6—brain cancer	3.62e-05	0.000325	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—NOTCH2—brain cancer	3.62e-05	0.000325	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—VAV1—brain cancer	3.58e-05	0.000321	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—IL2—brain cancer	3.58e-05	0.000321	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—PTCH1—brain cancer	3.56e-05	0.00032	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—SMO—brain cancer	3.56e-05	0.00032	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—PIK3CG—brain cancer	3.54e-05	0.000317	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—IL2—brain cancer	3.5e-05	0.000314	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	3.47e-05	0.000311	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—PIK3CG—brain cancer	3.46e-05	0.00031	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—VAV1—brain cancer	3.46e-05	0.00031	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—NOTCH2—brain cancer	3.45e-05	0.00031	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—HES1—brain cancer	3.41e-05	0.000306	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—IRS2—brain cancer	3.33e-05	0.000299	CbGpPWpGaD
Prazosin—ADRA1D—GPCR downstream signaling—IL2—brain cancer	3.3e-05	0.000296	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—VAV1—brain cancer	3.29e-05	0.000295	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—PDGFRA—brain cancer	3.25e-05	0.000291	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—PIK3CG—brain cancer	3.21e-05	0.000288	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—SPP1—brain cancer	3.15e-05	0.000283	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—PIK3CG—brain cancer	3.14e-05	0.000282	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—ENO2—brain cancer	3.11e-05	0.000279	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—HES1—brain cancer	3.08e-05	0.000276	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—NOTCH2—brain cancer	3.07e-05	0.000275	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—VEGFA—brain cancer	3.04e-05	0.000273	CbGpPWpGaD
Prazosin—ADRA2B—Hemostasis—TP53—brain cancer	3.03e-05	0.000272	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—IL2—brain cancer	3e-05	0.000269	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—IL2—brain cancer	2.98e-05	0.000268	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—HES1—brain cancer	2.97e-05	0.000267	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—APC—brain cancer	2.94e-05	0.000264	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—PIK3CG—brain cancer	2.94e-05	0.000264	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—PDGFRA—brain cancer	2.93e-05	0.000263	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—VAV1—brain cancer	2.92e-05	0.000262	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—PIK3CG—brain cancer	2.92e-05	0.000262	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—IL2—brain cancer	2.88e-05	0.000258	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—IRS2—brain cancer	2.85e-05	0.000256	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—NOTCH2—brain cancer	2.85e-05	0.000256	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—SPP1—brain cancer	2.85e-05	0.000255	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—HES1—brain cancer	2.83e-05	0.000254	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—PDGFRA—brain cancer	2.83e-05	0.000254	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—SPP1—brain cancer	2.75e-05	0.000246	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—IL2—brain cancer	2.74e-05	0.000246	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—VAV1—brain cancer	2.72e-05	0.000244	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—IL2—brain cancer	2.71e-05	0.000243	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—PDGFRA—brain cancer	2.69e-05	0.000242	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—EGFR—brain cancer	2.68e-05	0.00024	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—PIK3CG—brain cancer	2.64e-05	0.000237	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—SPP1—brain cancer	2.62e-05	0.000235	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—IL2—brain cancer	2.61e-05	0.000235	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—PIK3CG—brain cancer	2.61e-05	0.000234	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—IRS2—brain cancer	2.57e-05	0.000231	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—APC—brain cancer	2.52e-05	0.000226	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—PIK3CG—brain cancer	2.52e-05	0.000226	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—HES1—brain cancer	2.51e-05	0.000226	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—IL2—brain cancer	2.49e-05	0.000223	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—IRS2—brain cancer	2.48e-05	0.000223	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—IL2—brain cancer	2.43e-05	0.000218	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—PIK3CG—brain cancer	2.43e-05	0.000218	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—PDGFRA—brain cancer	2.39e-05	0.000215	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—IRS2—brain cancer	2.37e-05	0.000212	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—HES1—brain cancer	2.34e-05	0.00021	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—SPP1—brain cancer	2.32e-05	0.000209	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—TP53—brain cancer	2.3e-05	0.000206	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—RELA—brain cancer	2.3e-05	0.000206	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—EGFR—brain cancer	2.29e-05	0.000206	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—ERBB2—brain cancer	2.28e-05	0.000205	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—PIK3CG—brain cancer	2.27e-05	0.000204	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—APC—brain cancer	2.27e-05	0.000204	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—IL2—brain cancer	2.26e-05	0.000203	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—PDGFRA—brain cancer	2.22e-05	0.0002	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—IL2—brain cancer	2.21e-05	0.000198	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—PIK3CG—brain cancer	2.19e-05	0.000197	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—APC—brain cancer	2.19e-05	0.000197	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—SPP1—brain cancer	2.16e-05	0.000194	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—IRS2—brain cancer	2.1e-05	0.000189	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—APC—brain cancer	2.09e-05	0.000187	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—PIK3CG—brain cancer	2.09e-05	0.000187	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—EGFR—brain cancer	2.07e-05	0.000186	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—IL2—brain cancer	2.07e-05	0.000186	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—PIK3CG—brain cancer	2.06e-05	0.000185	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—IL2—brain cancer	2.05e-05	0.000184	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—CCND1—brain cancer	2.02e-05	0.000181	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—EGFR—brain cancer	2e-05	0.000179	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—CTNNB1—brain cancer	2e-05	0.000179	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—RELA—brain cancer	1.97e-05	0.000177	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—ERBB2—brain cancer	1.95e-05	0.000175	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—IRS2—brain cancer	1.95e-05	0.000175	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—EGFR—brain cancer	1.9e-05	0.000171	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—PIK3CG—brain cancer	1.86e-05	0.000167	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—APC—brain cancer	1.86e-05	0.000167	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—PIK3CG—brain cancer	1.79e-05	0.00016	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—RELA—brain cancer	1.78e-05	0.000159	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—IL2—brain cancer	1.77e-05	0.000159	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—ERBB2—brain cancer	1.76e-05	0.000158	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—VEGFA—brain cancer	1.76e-05	0.000158	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—STAT3—brain cancer	1.74e-05	0.000156	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—CCND1—brain cancer	1.73e-05	0.000155	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—PIK3CG—brain cancer	1.72e-05	0.000155	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—APC—brain cancer	1.72e-05	0.000155	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—RELA—brain cancer	1.71e-05	0.000154	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—CTNNB1—brain cancer	1.71e-05	0.000153	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—ERBB2—brain cancer	1.7e-05	0.000153	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—EGFR—brain cancer	1.69e-05	0.000152	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—RELA—brain cancer	1.63e-05	0.000147	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—ERBB2—brain cancer	1.62e-05	0.000146	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—MYC—brain cancer	1.62e-05	0.000145	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—IL2—brain cancer	1.6e-05	0.000144	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—EGFR—brain cancer	1.58e-05	0.000142	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—EGFR—brain cancer	1.57e-05	0.000141	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—CCND1—brain cancer	1.56e-05	0.00014	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—CTNNB1—brain cancer	1.54e-05	0.000139	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—IL2—brain cancer	1.54e-05	0.000139	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—VEGFA—brain cancer	1.51e-05	0.000135	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CCND1—brain cancer	1.51e-05	0.000135	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—STAT3—brain cancer	1.49e-05	0.000134	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CTNNB1—brain cancer	1.49e-05	0.000134	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—IL2—brain cancer	1.47e-05	0.000132	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—RELA—brain cancer	1.45e-05	0.00013	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—ERBB2—brain cancer	1.44e-05	0.000129	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CCND1—brain cancer	1.43e-05	0.000129	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—PIK3CG—brain cancer	1.43e-05	0.000128	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CTNNB1—brain cancer	1.42e-05	0.000127	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—MYC—brain cancer	1.39e-05	0.000124	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—VEGFA—brain cancer	1.36e-05	0.000122	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—EGFR—brain cancer	1.35e-05	0.000122	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—RELA—brain cancer	1.35e-05	0.000121	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—STAT3—brain cancer	1.35e-05	0.000121	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—ERBB2—brain cancer	1.34e-05	0.00012	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—TP53—brain cancer	1.33e-05	0.000119	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—VEGFA—brain cancer	1.31e-05	0.000118	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—IL2—brain cancer	1.31e-05	0.000117	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—STAT3—brain cancer	1.3e-05	0.000117	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CCND1—brain cancer	1.27e-05	0.000114	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CTNNB1—brain cancer	1.26e-05	0.000113	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—MYC—brain cancer	1.25e-05	0.000112	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—VEGFA—brain cancer	1.25e-05	0.000112	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—STAT3—brain cancer	1.24e-05	0.000111	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—EGFR—brain cancer	1.22e-05	0.00011	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—IL2—brain cancer	1.21e-05	0.000109	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—MYC—brain cancer	1.21e-05	0.000108	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CCND1—brain cancer	1.18e-05	0.000106	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—EGFR—brain cancer	1.18e-05	0.000106	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CTNNB1—brain cancer	1.17e-05	0.000105	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—MYC—brain cancer	1.15e-05	0.000103	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—TP53—brain cancer	1.14e-05	0.000102	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—EGFR—brain cancer	1.12e-05	0.000101	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—VEGFA—brain cancer	1.11e-05	9.96e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—STAT3—brain cancer	1.1e-05	9.86e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—VEGFA—brain cancer	1.03e-05	9.25e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—TP53—brain cancer	1.03e-05	9.22e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—MYC—brain cancer	1.02e-05	9.16e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—STAT3—brain cancer	1.02e-05	9.16e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—EGFR—brain cancer	9.99e-06	8.96e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—TP53—brain cancer	9.91e-06	8.9e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—MYC—brain cancer	9.49e-06	8.51e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—TP53—brain cancer	9.44e-06	8.47e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—EGFR—brain cancer	9.28e-06	8.33e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—TP53—brain cancer	8.39e-06	7.53e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—TP53—brain cancer	7.79e-06	6.99e-05	CbGpPWpGaD
